BamSEC and AlphaSense Join Forces
Learn More

Immunovant Inc.

NASDAQ: IMVT    
Share price (12/20/24): $25.86    
Market cap (12/20/24): $3.796 billion
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2024
Earnings Revised 11/09/24 Immunovant, Inc., Q2 2025 Earnings Call, Nov 07, 2024 11/07/24 Other Revised 09/27/24 Immunovant, Inc. - Special Call 09/09/24 Other Revised 01/09/24 Immunovant, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 07:30 AM 01/09/24
CY 2023
Other Revised 11/28/23 Immunovant, Inc. - Special Call 11/28/23 Other Revised 09/26/23 Immunovant, Inc. - Special Call 09/26/23
CY 2022
Other Revised 12/08/22 Immunovant, Inc. - Special Call 12/08/22 Other Revised 09/28/22 Immunovant, Inc. - Analyst/Investor Day 09/28/22 Other Revised 09/07/22 Immunovant, Inc. - Special Call 09/07/22 Earnings Revised 06/08/22 Immunovant, Inc., Q4 2022 Earnings Call, Jun 08, 2022 06/08/22 Other Revised 05/23/22 Immunovant, Inc. Presents at UBS Global Healthcare Conference, May-23-2022 01:15 PM 05/23/22 Other Revised 03/30/22 Immunovant, Inc. - Special Call 03/30/22 Other Revised 01/13/22 Immunovant, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-13-2022 09:45 AM 01/13/22 Other Revised 01/05/22 Immunovant, Inc. - Special Call 01/05/22
CY 2021
Other Revised 09/28/21 Immunovant, Inc. - Special Call 09/28/21 Earnings Revised 08/09/21 Immunovant, Inc., Q1 2022 Earnings Call, Aug 09, 2021 08/09/21 Earnings Revised 06/01/21 Immunovant, Inc., Q4 2021 Earnings Call, Jun 01, 2021 06/01/21 Other Revised 02/02/21 Immunovant, Inc. - Special Call 02/02/21
CY 2020
Other Revised 11/12/20 Immunovant, Inc. Presents at 29th Annual Virtual Healthcare Conference, Nov-12-2020 10:15 AM 11/12/20 Other Revised 08/25/20 Immunovant, Inc. - Special Call 08/25/20 Other Revised 08/19/20 Immunovant, Inc. - Shareholder/Analyst Call 08/19/20 Other Revised 03/30/20 Immunovant, Inc. - Special Call 03/30/20